A new study reveals that a long-term use of acid reflux and heartburn medications such as the proton pump inhibitors (PPIs) could increase the risk of developing stomach cancer. The risk anywhere could augment from two to eight times.
The findings of the study were published in Gut. The study was led by Dr. Wai Keung Leung, a professor of gastroenterology at the University of Hong Kong. He explained that while PPIs are one of the most commonly used medications for treating reflux disease and dyspepsia, clinicians should exercise caution when prescribing long-term PPIs. This includes patients who have H.pylori, as noted by the Web MD.
Dr. Leung advised the PPI users, especially those with past H.pylori infection to be cautious with the prolonged usage of PPIs. He added that doctors should review the indications and the needs of long-term PPIs in these patients.
0 comments :
Post a Comment